World's First Human Genome Editing with AI

A Breakthrough by Profluent

Profluent achieves the first-ever precision gene editing using AI-designed molecules, revolutionizing gene editing.

Profluent is renowned for AI-driven advancements in biotechnology, leading to this groundbreaking research.

AI capabilities were harnessed to design innovative gene editors, marking a significant advancement.

AI enables intentional protein design, shifting from traditional discovery-based methods.

Cas9 protein, an RNA-guided nuclease, plays a central role in gene editing systems.

Designing effective gene editors involves complex spatial and temporal interactions.

Researchers trained large language models on diverse CRISPR-based gene editing systems.

The extensive dataset includes millions of CRISPR-Cas proteins, expanding natural diversity.

AI-generated CRISPR-Cas proteins offer enhanced diversity for potential gene editing solutions.

AI-designed gene editors were evaluated in human cells, with OpenCRISPR-1 performing exceptionally.

This top-performing gene editor shows improved activity and specificity with reduced off-target effects.

Precision gene editing with AI-designed molecules marks a significant milestone in biotechnology.

Profluent releases OpenCRISPR-1 to democratize advanced gene editing technologies.

AI-driven innovation in biotechnology promises advancements in human health, agriculture, and scientific discovery.